Page 6 of 6
Are there plans for further studies?
Other studies on TDF in participants with chronic hepatitis B have been conducted and
some are ongoing. No further studies are planned at this time.
Where can I find more information about this study?
Clinical studies have unique study numbers that are included in publications and other
information about the study. The unique study number associated with this study is
shown below with an internet link to the scientific summary.
The scientific summary includes more details about the requirements for study
enrolment, the study visit schedule, results from other endpoints, and more detailed
information about adverse events.
Organisation and Website Study Number
United States National Institutes of Health (NIH)
NCT022244561
(www.clinicaltrials.gov)
Your doctor can help you understand more about this study and the results. Speak to
your doctor about the treatment options available in your country. You should not
make changes to your care based on the results of this or any single study. Keep taking
your current treatment unless instructed by your doctor.
We would like to thank the participants who contributed to this study. The results of
this study will help answer scientific questions about treating patients with chronic
hepatitis B.
The content for this document was finalised by GSK on 04 February 2022. The
information in this summary does not include additional information available after this
date.
1https://clinicaltrials.gov/ct2/show/NCT02224456